Skip to main content

Table 3 Laboratory data in HUS in children in Norway, 1999–2008

From: Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999–2008

Laboratory feature

Diarrhoea-associated HUS (N = 38)

Non-diarrhea-associated HUS (N = 9)

Hemoglobin at admission (median, g/dL)

11.1 (7.8–12.7) (N = 31)

6.7 (6.2–7.2) (N = 7)

Hemoglobin, minimum value (median, g/dL)

6.5 (5.8–7,5)

6.0 (5.9–6.2) (N = 8)

Creatinine at admission <1y (median, μmol/L)

35 (31–250) (N = 3)

86 (61–110) (N = 2)

Creatinine at admission ≥1y (median, μmol/L)

135 (61–275) (N = 25)

115 (110–132) (N = 5)

Creatinine, maximum value <1y (median, μmol/L)

231 (197–348) (N = 3)

97 (67–126) (N = 2)

Creatinine, maximum value ≥1y (median, μmol/L)

355 (200–465) (N = 35)

228 (124–307) (N = 6)

eGFR at admission <1y (median, ml/min/1,73 m2)

42.8 (23.0–49.1) (N = 3)

21.8 (12.4–31.2) (N = 2)

eGFR at admission ≥1y (median, ml/min/1,73 m2)

16.4 (11.0–58.5) (N = 25)

19.4 (18.5–28.0) (N = 5)

eGFR, minimum value <1y (median, ml/min/1,73 m2)

6.5 (4.9–7.8) (N = 3)

21.6 (12.1–31.0) (N = 2)

eGFR, minimum value ≥1y (median, ml/min/1,73 m2)

15.0 (6.3–13.8) (N = 35)

13.9 (7.6–21.8)

LDa at admission (median, U/L)

2241 (1153–2728) (N = 17)

2075 (1863–2659) (N = 5)

LD, maximum value (median, U/L)

3146 (2559–4023)

3090 (2441–5931) (N = 7)

Platelet count at admission (median, ×109/L)

59 (39–175) (N = 30)

39 (24–107) (N = 7)

Platelet count, minimum value (median, ×109/L)

32 (20–50)

24 (19–55) (N = 8)

CRPb at admission (median, mg/L)

14 (9–30) (N = 30)

13 (2–21) (N = 6)

CRP, maximum value (median, mg/L)

67 (19–138) (N = 37)

29 (15–161) (N = 7)

WBCc count at admission (median, ×109/L)

17.0 (11.2–25.4) (N = 29)

11.6 (9.4–14.1) (N = 7)

WBC count, maximum value (median, ×109/L)

19.4 (15.1–29.4)

16.0 (14.4–17.4) (N = 8)

Sodium at admission (median, μmol/L)

134 (130–137) (N = 27)

135 (130–135) (N = 6)

  1. Results are presented as number of cases, n (%) and median (interquartile range). If data on the feature was not available in all medical records, the number of cases where available is presented with (N = number of cases where available). Estimated glomerular filtration rate (eGFR) was estimated retrospectively using the height-independent Pottel eGFR equation [29]. HUS hemolytic uremic syndrome
  2. aLD Lactate dehydrogenase
  3. bCRP C-reactive protein
  4. cWBC white blood cell